Nilotinib and dasatinib are good options for you
Sending you the reference chart for the same
https://www.semanticscholar.org/paper/Bcr-Abl-kinase-domain-mutations%2C-drug-resistance%2C-a-O%27hare-Eide/583d573087203c6d3a48041556f16f8f472eba3c
Answered2025-01-15 17:48:19
1/1 people found this helpful